Get started
Author

Ceren Sezgın

Observed names: C. Sezgin, Ceren SEZGİN, Ceren Sezgin, Ceren Sezgin Arıkbası
ORCID: 0000-0003-2166-4490
Observed ORCID: 0000-0003-2166-4490
OpenAlex ID: A5051284366
The radiolabeling of [161Tb]Tb-PSMA-617 by a novel radiolabeling method and preclinical evaluation by in vitro/in vivo methods
2024 · Emre Uygur, Ceren Sezgin, et al. · Journal of Radioanalytical and Nuclear Chemistry · 14
PDF
Unexpected Metastatic Localizations of Prostate Cancer Determined by 68Ga PSMA PET/CT: Series of Four Cases
2022 · Gözde Mütevelizade, Ceren Sezgin, et al. · Molecular Imaging and Radionuclide Therapy · 11
PDF
Initial Multicenter Experience with [ 161 Tb]Tb-PSMA in [ 177 Lu]Lu-PSMARefractory Metastatic Castration-Resistant Prostate Cancer: Preliminary Results
2025 · Nuriye Ozlem Kucuk, Nazim Coskun, et al. · Journal of Nuclear Medicine · 7
Effective Half-life, Excretion and Radiation Exposure of 177lu-psma
2023 · Yasemin Parlak, Gozde Mutevelızade, et al. · Radiation Protection Dosimetry · 6
Synthesis of Novel Plant-Derived Encapsulated Radiolabeled Compounds for the Diagnosis of Parkinson’s Disease and the Evaluation of Biological Effects with In Vitro/In Vivo Methods
2024 · Emre Uygur, Kadriye Büşra Karatay, et al. · Molecular Neurobiology · 5
PDF
A Comprehensive Analysis of Volumetric 68Ga-PSMA PET/CT Parameters, Clinical and Histopathologic Features: Evaluation of the Predictive Role
2024 · Gözde Mutevelizade, Yasemin Parlak, et al. · Molecular Imaging and Radionuclide Therapy · 4
Terbium-161 PSMA therapy in mCRPC patient based on an optimized radiolabeling protocol
2025 · Ceren Sezgin, Emre Uygur, et al. · Journal of Radioanalytical and Nuclear Chemistry · 2
Inguinoscrotal Bladder Hernia Mimicking Testicle Tumor
2023 · Ceren Sezgin, Fatih Duzgun, et al. · Clinical Medicine Insights Case Reports · 2
FDG PET Görüntülemelerin Kantitatif Değerlendirilmesi
2021 · Ceren Sezgin, Yasemin Parlak, et al. · Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi · 1
PDF
The role of [68Ga]Ga-DOTA-TATE PET/CT in breast cancer imaging: a prospective study compared with [18F]FDG PET/CT
2025 · Ceren Sezgin, Yasemin Parlak, et al. · Clinical and Translational Imaging
Predicting thyroid cancer ablation success: Pre-ablative 99mTc-Pertechnetate and post-ablative 131I scan comparison
2024 · G. Mutevelizade, Y. Parlak, et al. · Médecine Nucléaire
Alisertib'in İyot-123 ile Radyoişaretlenme Potansiyelinin Araştırılması: Aurora A Kinaz İnhibitörünün Görüntülenme Potansiyelinin Değerlendirilmesi
2024 · Emre Uygur, Ceren Sezgin, et al. · Afyon Kocatepe University Journal of Sciences and Engineering
PDF
Splenosis imaging with 99mTc nano-colloid as a different mimicker in a lymphoma patient on 18F- FDG PET/CT
2024 · C. Sezgin, Y. Parlak, et al. · Médecine Nucléaire
Relationship Between Initial Volumetric 68Ga-PSMA PET/CT Parameters, and Clinical and Histopathological Data in Patients with Newly Diagnosed Prostate Cancer
2023 · GÖZDE MÜTEVELİZADE, Ceren Sezgin Arıkbası, et al. · Research Square
PDF
Radiolabeling fingolimod with technetium-99 m and evaluating its biological affinity by in vitro method
2023 · E. Uygur, Y. Parlak, et al. · Journal of Radioanalytical and Nuclear Chemistry
Contribution of Open Mouth Technique in 18F-FDG PET/CT Imaging in Patients with Malignant Lip Neoplasm
2022 · Gözde Mütevelizade, Ceren Sezgin, et al. · Molecular Imaging and Radionuclide Therapy
PDF
Unexpected Metastatic Localization of Prostate Cancer Determined by Ga-68 PSMA PET/CT: Choroid
2022 · Gözde MÜTEVELİZADE, Ceren SEZGİN, et al. · Turkiye Klinikleri Journal of Case Reports
PDF
Works count: 17
Citation count: 52
H-index: 5
I10-index: 2
Year
Topic
Type